Fortress Biotech, Inc.
FBIO
$2.72
$0.010.37%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -103.02% | 1,142.83% | 41.80% | 145.47% | 241.45% |
| Total Depreciation and Amortization | -8.04% | 2.35% | 2.84% | 20.90% | -2.94% |
| Total Amortization of Deferred Charges | -50.55% | 393.22% | 13.00% | -17.99% | -40.34% |
| Total Other Non-Cash Items | 82.63% | 527.75% | 138.28% | -200.57% | -259.03% |
| Change in Net Operating Assets | -617.18% | 2,547.92% | -88.47% | 18.71% | -201.21% |
| Cash from Operations | -115.08% | 1,142.02% | 2.81% | 69.54% | -26.20% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -101.30% | -- | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -2,219.04% | 108.80% | 79.20% | -- |
| Issuance of Common Stock | -62.46% | 27.82% | -38.87% | -77.60% | -73.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 100.00% | -9,456.67% | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -464.24% | -- | -74.75% | 134.91% | -55.11% |
| Cash from Financing | -97.99% | -152.53% | -77.88% | 455.96% | -68.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -249.58% | 422.94% | -225.42% | 168.20% | -123.86% |